Literature DB >> 7286039

Antifolate effect of triamterene on human leucocytes and on a human lymphoma cell line.

A Schalhorn, W Siegert, H J Sauer.   

Abstract

The inhibitory effect of triamterene and its metabolites on human leucocyte dihydrofolate reductase has been studied. Under test conditions with dihydrofolic acid 0.5 X 10(-5) M, triamterene 7 X 10(-5) M produced total enzyme inhibition, whereas the metabolites hydroxytriamterene and the sulphate ester of hydroxytriamterene were less effective inhibitors; at their maximum attainable concentration of 5 X 10(-5) M, dihydrofolate reductase was inhibited by 80% and 50%, respectively. Cultures of the BJAB-B95-8 human lymphoma cell line were incubated with various concentrations of triamterene. Because of their increased specific activity of dihydrofolate reductase, the cells were able to maintain normal DNA metabolism, as measured by the ratio of the incorporation rates of 3H-deoxyuridine and 3H-thymidine, as well as normal cell growth at 1 X 10(-6) M, and in some cases at 1 X 10(-5) M triamterene. At 8 X 10(-5) M triamterene, the strong inhibitory effect caused severe impairment of DNA metabolism and subsequently dissolution of the cell culture. The results are discussed in relation to the possible toxic side effects of long-term triamterene treatment in patients suffering from alcoholic cirrhosis, who may have impaired metabolism of triamterene and a concomitant severe folate deficiency.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286039     DOI: 10.1007/BF00544601

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  [DRUG-RELATED DISORDERS OF BLOOD CELL MATURATION BY INHIBITION OF THE FOLIC ACID METABOLISM ENZYME].

Authors:  W WILMANNS; A HAMFELT
Journal:  Verh Dtsch Ges Inn Med       Date:  1964

2.  Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.

Authors:  K O Fresen; H Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

3.  [Acute pancytopenia and medullary megaloblastosis in a cirrhotic patient treated with triamterene].

Authors:  M Renoux; J F Bernard; M Amar; P Boivin
Journal:  Nouv Presse Med       Date:  1976-03-06

4.  Effects of methotrexate on cellular metabolism: some critical elements in the drug-cell interaction.

Authors:  I D Goldman
Journal:  Cancer Treat Rep       Date:  1977-07

5.  "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.

Authors:  J R Bertino
Journal:  Semin Oncol       Date:  1977-06       Impact factor: 4.929

6.  Membrane transport of methotrexate in human lymphoblastoid cells.

Authors:  R D Warren; A P Nichols; R A Bender
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

7.  Megaloblastic anemia possibly induced by triamterene in patients with alcoholic cirrhosis. Two case reports.

Authors:  F L Lieberman; J R Bateman
Journal:  Ann Intern Med       Date:  1968-01       Impact factor: 25.391

8.  Mechanism of triamterene-induced megaloblastosis.

Authors:  J Corcino; S Waxman; V Herbert
Journal:  Ann Intern Med       Date:  1970-09       Impact factor: 25.391

9.  [On the determination of triamterene, hydroxythiamterene and hydroxytriamterene sulphate ester in biologica material by direct evaluation of thin-layer chromatograms (author's transl)].

Authors:  B Grebian; H E Geissler; E Mutschler
Journal:  Arzneimittelforschung       Date:  1976

10.  [Pharmacokinetics of triamterene and its active metabolites in renal insufficiency (author's transl)].

Authors:  B Grebian; H E Geissler; H Knauf; E Mutschler; I Schnippenkoetter; K D Völger; U Wais
Journal:  Arzneimittelforschung       Date:  1978
View more
  4 in total

1.  Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Authors:  Jing Yuan; Ronald L Johnson; Ruili Huang; Jennifer Wichterman; Hongying Jiang; Karen Hayton; David A Fidock; Thomas E Wellems; James Inglese; Christopher P Austin; Xin-zhuan Su
Journal:  Nat Chem Biol       Date:  2009-09-06       Impact factor: 15.040

2.  Triamterene induces autophagic degradation of lysosome by exacerbating lysosomal integrity.

Authors:  Na Yeon Park; Doo Sin Jo; Yong Hwan Kim; Ji-Eun Bae; Joon Bum Kim; Hyun Jun Park; Ji Yeon Choi; Ha Jung Lee; Jeong Ho Chang; Heeyoun Bunch; Hong Bae Jeon; Yong-Keun Jung; Dong-Hyung Cho
Journal:  Arch Pharm Res       Date:  2021-06-07       Impact factor: 4.946

3.  Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs.

Authors:  Damir Jacob Illich; Miao Zhang; Andrei Ursu; Rodrigo Osorno; Kee-Pyo Kim; Juyong Yoon; Marcos J Araúzo-Bravo; Guangming Wu; Daniel Esch; Davood Sabour; Douglas Colby; Kathrin S Grassme; Jiayu Chen; Boris Greber; Susanne Höing; Wiebke Herzog; Slava Ziegler; Ian Chambers; Shaorong Gao; Herbert Waldmann; Hans R Schöler
Journal:  Cell Rep       Date:  2016-04-14       Impact factor: 9.423

Review 4.  Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.

Authors:  Emily S Mohn; Hua J Kern; Edward Saltzman; Susan H Mitmesser; Diane L McKay
Journal:  Pharmaceutics       Date:  2018-03-20       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.